Cargando…
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
Background and Aims: Ulcerative colitis (UC) is a chronic inflammatory disease. Fecal microbial transplantation (FMT) is a promising alternative treatment. Methods: This multicenter, open-label, noninferiority trial randomized patients with active left-sided UC (Mayo score 4–10) equally to FMT or 5-...
Autores principales: | Březina, Jan, Bajer, Lukáš, Wohl, Pavel, Ďuricová, Dana, Hrabák, Pavel, Novotný, Aleš, Koželuhová, Jana, Lukáš, Milan, Mrázek, Jakub, Fliegerová, Kateřina Olša, Kvasnová, Simona, Chahrazed, Mekadim, Mareš, Jan, Špičák, Julius, Drastich, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268406/ https://www.ncbi.nlm.nih.gov/pubmed/34206663 http://dx.doi.org/10.3390/jcm10132753 |
Ejemplares similares
-
Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy
por: Schierová, Dagmar, et al.
Publicado: (2020) -
Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
por: Brezina, Jan, et al.
Publicado: (2022) -
Host Species Affects Bacterial Evenness, but Not Diversity: Comparison of Fecal Bacteria of Cows and Goats Offered the Same Diet
por: Mahayri, Tiziana Maria, et al.
Publicado: (2022) -
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
por: Bajer, Lukas, et al.
Publicado: (2017) -
Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018)